ST6GAL2
Beta-galactoside alpha-2,6-sialyltransferase 2
Also known as: KIAA1877, SIAT2, SIAT2_HUMAN, St6GalII
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JF0
- Gene
- ST6GAL2
- Ensembl
- ENSG00000144057
- Chromosome
- 2
- Canonical length
- 529 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
This locus encodes a sialyltransferase. The encoded type II transmembrane protein catalyzes the transfer of sialic acid from CMP to an oligosaccharide substrate. Polymorphisms at this locus may be associated with variations in risperidone response in schizophrenic patients. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>Q96JF0|ST6GAL2
1 MKPHLKQWRQ RMLFGIFAWG LLFLLIFIYF TDSNPAEPVP SSLSFLETRR LLPVQGKQRA
61 IMGAAHEPSP PGGLDARQAL PRAHPAGSFH AGPGDLQKWA QSQDGFEHKE FFSSQVGRKS
121 QSAFYPEDDD YFFAAGQPGW HSHTQGTLGF PSPGEPGPRE GAFPAAQVQR RRVKKRHRRQ
181 RRSHVLEEGD DGDRLYSSMS RAFLYRLWKG NVSSKMLNPR LQKAMKDYLT ANKHGVRFRG
241 KREAGLSRAQ LLCQLRSRAR VRTLDGTEAP FSALGWRRLV PAVPLSQLHP RGLRSCAVVM
301 SAGAILNSSL GEEIDSHDAV LRFNSAPTRG YEKDVGNKTT IRIINSQILT NPSHHFIDSS
361 LYKDVILVAW DPAPYSANLN LWYKKPDYNL FTPYIQHRQR NPNQPFYILH PKFIWQLWDI
421 IQENTKEKIQ PNPPSSGFIG ILIMMSMCRE VHVYEYIPSV RQTELCHYHE LYYDAACTLG
481 AYHPLLYEKL LVQRLNMGTQ GDLHRKGKVV LPGFQAVHCP APSPVIPHSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ST6GAL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 34 nTPM
- thyroid gland: 27 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 11 nTPM
- testis: 5 nTPM
- gallbladder: 4.8 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 183 nCPM
- sertoli cells: 151 nCPM
- megakaryocyte progenitors: 149 nCPM
- astrocytes: 79 nCPM
- bergmann glia: 77 nCPM
- retinal amacrine cells: 74 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 63 nTPM
- amygdala: 54 nTPM
- basal ganglia: 53 nTPM
- hypothalamus: 50 nTPM
- white matter: 39 nTPM
- hippocampal formation: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 6-sialyltransferase activity
- beta-galactoside alpha-2
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ST6GAL2 as an antibody target. Whether an autoantibody or antibody against ST6GAL2 could matter depends on whether native ST6GAL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ST6GAL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ST6GAL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...